3% of medicines are of poor quality: Survey -Governance Now

3% of medicines are of poor quality: Survey

The survey found that out of the 47,012 samples tested, 13 samples were spurious and 1,850 samples were not of standard quality (NSQ).

GN Bureau | February 25, 2017

#Health ministry #medicines #poor quality #spurious #India news

More than three percent of medicines in India are ‘Not of Standard Quality’ (NSQ) and 0.0245 percent spurious, reveals a survey report on drugs quality by the ministry of health.

The survey carried out by National Institute of Biologicals (NIB), Noida found that out of the 47,012 samples tested, 13 samples were spurious and 1,850 samples were NSQ.

It is the largest ever scientifically designed and professionally executed drug survey undertaken in the world for determining the quality of drugs, a press statement released by the ministry said.

Read: Pause before you pop, it may be spurious

It included as many as 224 drug molecules belonging to 15 different therapeutic categories of the National List of Essential Medicines (NLEM) 2011. As part of this survey, 47,954 drug samples relating to 23 dosage forms were drawn from 654 districts of 36 states and union territories from the supply chains including retail outlets, government sources and from eight airports and sea ports.

All the samples were subjected to test and analysis in the central and state drug testing laboratories that have been accredited by National Accreditation Board for Testing and Calibration Laboratories (NABL). A nationwide training in drugs survey methodology was imparted at 28 centres across the country to over 1800 Sample Drawing Officers (SDOs) and representatives of the Civil society / pharmacy council of India (PCI).

They observed that the drugs samples are drawn in accordance with the sampling methodology and the highest degree of transparency and objectivity is maintained in the process to eliminate any bias.

Comments

Other News

How Rafi, Raj Kapoor helped pave the way for a great uranium deal

There`s a certain moment in diplomacy that`s too personal to be captured in a communiqué, too small to make the front page, but more revealing than the front page. This week, prime minister Narendra Modi reached Tashkent and, amid the pomp of state visits, managed to evoke the old Bollywood tunes

Distinguishing Fish 1 and Fish 2: The pragmatism behind India’s WTO ratification

India became the 123rd WTO member to ratify the multilateral Agreement on Fisheries subsidies (AoFS) when it deposited the Instrument of Acceptance for Phase 1 on July 20, 2026. The ratification is restricted to disciplining Illegal, Unreported and Unregulated fishing (IUU), protection for overfished

The 7% growth problem: Why the next 7% will be harder

India has become accustomed to hearing the 7% growth number. It is now less a milestone than an expectation. Yet the paradox is becoming clearer: maintaining 7% growth may be considerably harder than achieving it once. India’s real GDP grew 7.7% in FY2025–26, following growth of 6.5% in FY202

The Constitution cannot be altered: Justice Abhay Oka

Justice Abhay Oka, who retired from the Supreme Court in May 2025, has said that the Constitution of India cannot be altered. Explaining the landmark Kesavananda Bharati judgment (1973) on the basic structure of the Constitution, he said, “This is one judgment that has saved democracy in India.&rdq

How the flora and fauna evolved in the Indian subcontinent

Mammals of India By A.J.T. Johnsingh and P.O. Nameer HarperCollins India in association with Bombay Natural History Society

India`s renewable race is moving beyond megawatts

When Shell bought Sprng Energy in 2022, India`s renewable energy market appeared to offer precisely what global energy majors were seeking: scale, growth and a place in one of the world`s largest energy transitions. Four years later, Shell is selling the same business to Aditya Birla Group for an enterpris